Perinatal Neonatal Quality Improvement Network Spring Summit, 4/12/23
Claiming Credit for Session
Thank you for attending PNQIN Spring Summit meeting on April 12, 2023. Once logged in, please click on "Take Course" on the right-hand side and your enrollment will be recorded. You will be prompted to take an evaluation to claim your credit on the following page.
Educational Needs Addressed
In this meeting, PNQIN reviewed their latest projects, their role in driving change in maternal and neonatal inequities and how they can better integrate families into quality improvement work. The goal is to improve attendees understanding of patient, family and community engagement in advancing equity in maternal and neonatal care.
PNQIN providers including physicians, nurses, nurse practitioners, physician assistants and social workers.
At the completion of this activity, pharmacists will be able to:
- Describe short- and long- term goals of the PNQIN and collaborator equity-focused projects
- Describe the role of perinatal quality collaboratives in addressing maternal and neonatal inequities
- Identify areas of maternal and neonatal care where racial and ethnic disparities exist
- Implement strategies to disaggregate data by race and ethnicity to identify the needs of subpopulations
- Understand the importance of patient, family and community engagement in advancing equity in maternal and neonatal care
Faculty Presenters and Disclosures
Martha Richardson, MD
Obstetrics and Gynecology
Harvard Vanguard Medical Associates
The Copley Center
Drs. Benedict, DeGroot, Fitzpatrick, Flanagan, Krier, Leotsakos, Oyelese , Pennie, Psoinnos, Stefansson have no relevant financial relationships to disclose.
Planning Committee and Disclosures
Meghan Bride, NP; Erin Brooks, MD, Caroline Elich, RN; Deborah Platek, MD; Martha Richardson, MD; and Payal Srinivasas, MD, of Atrius Health have no relevant financial relationships to disclose.
The following planning committee members from Boston University Chobanian & Avedisian School of Medicine’s Office of Continuing Medical Education have no relevant financial relationships with ineligible companies:
Michael Burk, BS – Operations Manager
Accreditor Disclosure Policy
Boston University Chobanian & Avedisian School of Medicine asks all individuals involved in the development and presentation of Accredited Continuing Education activities to disclose all financial relationships with ineligible companies. This information is disclosed to all activity participants prior to the start of the educational activity. Boston University Chobanian & Avedisian School of Medicine has procedures to mitigate all relevant financial relationships with ineligible companies. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.
In accordance with the Standards for Integrity and Independence in Accredited Continuing Education, all relevant financial relationships with ineligible companies that faculty, planners, authors and anyone who may be in control of content have been mitigated.
The faculty members do not plan on discussing the unlabeled/investigational use of any commercial products.
In support of improving patient care, this activity has been planned and implemented by Boston University Chobanian & Avedisian School of Medicine and Perinatal Neonatal Quality Improvement Network (PNQIN). Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Boston University Chobanian & Avedisian School of Medicine designates this live activity for a maximum of 6.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Contact Hours: 6.5
Social Work Accreditation
This course has been approved for Social Work Accreditation by Boston University's School of Social Work for 6.5 CECs.
Authorization Code: B-24-262
Opioid Education/Pain Management Training
This program meets the criteria of the Massachusetts Board of Registration in Medicine for 2 hours of opioid education
- 3.50 AMA PRA Category 1 Credit™
Boston University Chobanian & Avedisian School of Medicine designates this Live activity for a maximum of 3.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 3.50 MA Risk Management
- 3.33 ANCC
- 1.33 ANCC Pharmacology
- 3.50 Participation